Φορτώνει......
Immunotherapy of advanced renal cell carcinoma: Current and future therapies
Previously a malignancy with few therapeutic options, metastatic renal cell carcinoma (mRCC) treatment is rapidly evolving. Although cytokine therapies (interferon-a, interleukin-2) have been used less frequently over the past decade, recent approval of an immune checkpoint inhibitor, nivolumab, has...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Hum Vaccin Immunother |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215367/ https://ncbi.nlm.nih.gov/pubmed/27494417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1212794 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|